Progress in the development of in vivo redox measurements: New tools for longitudinal studies in Rett syndrome

Neurosci Biobehav Rev. 2019 Sep:104:28-29. doi: 10.1016/j.neubiorev.2019.06.014. Epub 2019 Jun 26.

Authors

Angelisa Frasca¹, Francesco Bedogni², Nicoletta Landsberger³

Affiliations

¹ Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, 20100, Italy.
² Neuroscience Division, IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.
³ Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, 20100, Italy; Neuroscience Division, IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy. Electronic address: nicoletta.landsberger@unimi.it.

PMID: 31254541
DOI: 10.1016/j.neubiorev.2019.06.014

No abstract available

Publication types

Comment

MeSH terms

Humans
Longitudinal Studies
Methyl-CpG-Binding Protein 2
Oxidation-Reduction
Rett Syndrome*

Substances

Methyl-CpG-Binding Protein 2